HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.

AbstractBACKGROUNDS:
The totally subcutaneous implantable defibrillator (S-ICD) has been designed as a new alternative to conventional implantable defibrillators. This system is especially attractive for young patients. However, long-term experience is not yet available. To address the question whether the S-ICD system is safe and feasible for young patients with electrical heart disease or idiopathic ventricular fibrillation (VF), the data of a standard of care prospective single center S-ICD registry were evaluated.
METHODS:
In the present study, 24 patients (age 34.2 ± 11.5 years) with electrical heart disease or idiopathic VF received an S-ICD for primary (n = 8) or secondary prevention (n = 16). The mean follow-up duration was 29.6 ± 15.1 months.
RESULTS:
Ventricular arrhythmias were adequately detected in four patients (17 %). In three patients (13 %) oversensing was noticed and led to at least one inappropriate shock in two patients (8 %). Further adverse events included surgical revision due to a mobile pulse generator as well as explantation of one system and switch to a transvenous ICD system due to several ineffective shocks.
CONCLUSIONS:
The results of the present study suggest that S-ICD therapy may be an attractive alternative in young patients with electrical heart disease or idiopathic VF. However, episodes of oversensing as well as ineffective shocks may occur.
AuthorsGerrit Frommeyer, Dirk G Dechering, Simon Kochhäuser, Markus Bettin, Julia Köbe, Lars Eckardt, Florian Reinke
JournalJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (J Interv Card Electrophysiol) Vol. 47 Issue 2 Pg. 185-188 (Nov 2016) ISSN: 1572-8595 [Electronic] Netherlands
PMID27217031 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Adult
  • Death, Sudden, Cardiac (prevention & control)
  • Defibrillators, Implantable
  • Equipment Design
  • Equipment Failure Analysis
  • Feasibility Studies
  • Female
  • Heart Failure (diagnosis, prevention & control)
  • Humans
  • Longitudinal Studies
  • Male
  • Treatment Outcome
  • Ventricular Fibrillation (diagnosis, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: